Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Daydreaming linked to Alzheimer's disease

According to new research, Alzheimer's disease may be due to abnormalities in the regions of the brain that operate the "default state", a term used to describe the cognitive state people defer to when musing, daydreaming, or thinking to themselves.

30 Aug 2005

First genetic evidence that protein synthesis is critical for the regulation of memory formation

A group of Montreal researchers has discovered that GCN2, a protein in cells that inhibits the conversion of new information into long-term memory, may be a master regulator of the switch from short-term to long-term memory.

29 Aug 2005

Ataxin-1 affects the development of the nervous system

In some neurological diseases, too much of what is usually a good thing can be bad, said researchers at Baylor College of Medicine in a report in this week's issue of the journal Cell.

28 Aug 2005

Scientists have developed a new dye that could offer noninvasive early diagnosis of Alzheimer's disease

MIT scientists have developed a new dye that could offer noninvasive early diagnosis of Alzheimer's disease, a discovery that could aid in monitoring the progression of the disease and in studying the efficacy of new treatments to stop it.

26 Aug 2005

Parts of the brain used in daydreaming are the same areas that fail in people who have Alzheimer's disease

Researchers who used five different medical imaging techniques to study the brain activity of 764 people, including those with Alzheimer's disease, those on the brink of dementia, and healthy individuals, have found that the areas of the brain that young, healthy people use when daydreaming are the same areas that fail in people who have Alzheimer's disease.

25 Aug 2005

Coronary angioplasty increases risk of developing Alzheimer's disease

Boston University School of Medicine (BUSM) researchers have discovered that patients who have either coronary artery bypass graft surgery or coronary angioplasty are at an increased risk of developing Alzheimer's disease.

25 Aug 2005

New drug CX717 can temporarily improve performance and reverse the effects of sleep deprivation

Research in monkeys suggests that a new drug can temporarily improve performance and reverse the effects of sleep deprivation on the brain, which would be a breakthrough in helping shift workers, health professionals, military personnel and others who must function at top performance in spite of sleep deficits.

23 Aug 2005

Biochemical switch that affects how neurons fire in a part of the brain associated with learning

Researchers at UT Southwestern Medical Center have identified a biochemical switch that affects how neurons fire in a part of the brain associated with learning, findings that may aid in understanding schizophrenia and Alzheimer's disease.

17 Aug 2005

Breakthrough in human stem cell research

A breakthrough in human stem cell research, producing embryonic-like cells from umbilical cord blood may substantially speed up the development of treatments for life-threatening illnesses, injuries and disabilities.

16 Aug 2005

Method to propagate mouse brain stem cells derived from ES cells

It's hard to grow stem cells in a dish. In particular, while it is possible to multiply mouse embryonic stem cells in culture, propagating stem cells that are specific to distinct tissues (e.g. neural stem cells) has proven to be a challenge.

16 Aug 2005

Key toxin could provide for world's first treatment for Alzheimer's

Dr Karen Cullen at Sydney University’s Institute for Biomedical Research is part of a collaborative team which has identified a key component in the progression of Alzheimer’s disease, a finding which may produce the world’s first effective treatment to combat the debilitating effects of the disease.

15 Aug 2005

Folates best at preventing Alzheimer's disease

According to results from a long-term study on aging, adults who eat the daily recommended allowance of folates significantly reduce their risk of developing Alzheimer's disease.

15 Aug 2005

Vitamin B reduces risk of developing Alzheimer's disease

Adults who eat the daily recommended allowance of folates - B-vitamin nutrients found in oranges, legumes, leafy green vegetables and folic acid supplements - significantly reduce their risk of developing Alzheimer's disease, according to results from a long-term National Institute on Aging study of diet and brain aging.

13 Aug 2005

Key step in the production of beta-amyloid

Researchers at UT Southwestern Medical Center have defined a key step in the production of beta-amyloid, a short protein that is thought to be responsible for the development of Alzheimer's disease. Understanding this step may aid in the discovery of drugs that could help block the disease from developing.

11 Aug 2005

Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer's disease

Alzheimer disease (AD) is the most common form of senile dementia, with no effective treatment available. In a study appearing online on August 11 in advance of print publication of the September 1 issue of the Journal of Clinical Investigation, Howard Weiner and colleagues from Harvard describe a novel immunologic approach for the treatment of AD.

11 Aug 2005

Early detection of Alzheimer's coming soon?

Alzheimer's disease is the most common form of old-age dementia and has become the fourth most common cause of death in the USA. The cause of the disease is protein deposits, called amyloid plaques, in the brain.

11 Aug 2005

High insulin levels increase inflammatory markers and beta-amyloids

Moderately elevated levels of insulin increase the levels of inflammatory markers and beta-amyloid in plasma and in cerebrospinal fluid, and these markers may contribute to Alzheimer's disease, according to a new study posted online today from Archives of Neurology, one of the JAMA/Archives journals.

9 Aug 2005

Australian researchers have found a toxin that plays an important role in the progression of Alzheimer's disease

The research, which is led by two University of New South Wales academics, is significant because drugs that are in the advanced developmental phase for other conditions might be able to be used on Alzheimer's patients, to halt the disease progressing.

4 Aug 2005

Early warning aigns of Alzheimer's show up across cognitive areas years before official diagnosis

By combing through dozens of Alzheimer's disease (AD) studies, psychologists have gained a clear picture of cognitive problems in people who will develop the degenerative brain disease.

4 Aug 2005

Breakthrough in Alzheimer's research

This week scientists of the Flanders Interuniversity Institute for Biotechnology (VIB) will once again publish a breakthrough in their research regarding Alzheimer's disease.

3 Aug 2005

Alzheimer's Disease News and Research

Further Reading

Daydreaming linked to Alzheimer's disease

First genetic evidence that protein synthesis is critical for the regulation of memory formation

Ataxin-1 affects the development of the nervous system

Scientists have developed a new dye that could offer noninvasive early diagnosis of Alzheimer's disease

Parts of the brain used in daydreaming are the same areas that fail in people who have Alzheimer's disease

Coronary angioplasty increases risk of developing Alzheimer's disease

New drug CX717 can temporarily improve performance and reverse the effects of sleep deprivation

Biochemical switch that affects how neurons fire in a part of the brain associated with learning

Breakthrough in human stem cell research

Method to propagate mouse brain stem cells derived from ES cells

Key toxin could provide for world's first treatment for Alzheimer's

Folates best at preventing Alzheimer's disease

Vitamin B reduces risk of developing Alzheimer's disease

Key step in the production of beta-amyloid

Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer's disease

Early detection of Alzheimer's coming soon?

High insulin levels increase inflammatory markers and beta-amyloids

Australian researchers have found a toxin that plays an important role in the progression of Alzheimer's disease

Early warning aigns of Alzheimer's show up across cognitive areas years before official diagnosis

Breakthrough in Alzheimer's research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News